Tatiana Olivares-Bañuelos

Dr. Tatiana Olivares-Bañuelos

Instituto de Investigaciones Oceanológicas, Universidad Autónoma de Baja California, Ensenada, Baja California, Mexico
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Drug Discovery Today
Verified
Journal Article
Closed access
AGAnllely G. Gutiérrez-Rodríguez
Anllely G. Gutiérrez-Rodríguez
CJClaudia Juárez-Portilla
Claudia Juárez-Portilla
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
RZRossana C Zepeda
Rossana C Zepeda

11 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
AGAnllely G. Gutiérrez-Rodríguez
Anllely G. Gutiérrez-Rodríguez
RMRodolfo Méndez-Bellido
Rodolfo Méndez-Bellido
RTRicardo Tovar-Miranda
Ricardo Tovar-Miranda
OAOmar Arroyo-Helguera
Omar Arroyo-Helguera
RZRossana C Zepeda
Rossana C Zepeda
Brown seaweeds contain bioactive compounds that show anti-tumorigenic effects. These characteristics have been repeatedly observed in the Lessoniaceae family. Egregia menziesii, a member of this family, is distributed in the North Pacific and its properties have been barely studied. We evaluated herein the cytotoxic and anti-proliferative activity of extracts of this seaweed, through toxicity assay in Artemia salina and lymphocytes, and MTT proliferation assay, in Bergmann glia cells, 3T3-L1 and brain cancer cell lines. E. menziesii’s extracts inhibited the spread of all the tested cell lines. The hexane extract showed the highest cytotoxic activity, while the methanol extract was moderately cytotoxic. Interestingly, seaweed extracts displayed a selective inhibition pattern. These results suggest that E. menziesii’s extracts might be good candidates for cancer prevention and the development of novel chemotherapies due to its highest cytotoxicity in transformed cells compare to glia primary cultures.

18 February 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
AOArturo Ortega
Arturo Ortega
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
The nervous system (NS) of invertebrates and vertebrates is composed of two main types of cells: neurons and glia. In both types of organisms, nerve cells have similarities in biochemistry and functionality. The neurons are in charge of the synapse, and the glial cells are in charge of important functions of neuronal and homeostatic modulation. Knowing the mechanisms by which NS cells work is important in the biomedical area for the diagnosis and treatment of neurological disorders. For this reason, cellular and animal models to study the properties and characteristics of the NS are always sought. Marine invertebrates are strategic study models for the biological sciences. The sea slug Aplysia californica and the squid Loligo pealei are two examples of marine key organisms in the neurosciences field. The principal characteristic of marine invertebrates is that they have a simpler NS that consists of few and larger cells, which are well organized and have accessible structures. As well, the close phylogenetic relationship between Chordata and Echinodermata constitutes an additional advantage to use these organisms as a model for the functionality of neuronal cells and their cellular plasticity. Currently, there is great interest in analyzing the signaling processes between neurons and glial cells, both in vertebrates and in invertebrates. However, only few types of glial cells of invertebrates, mostly insects, have been studied, and it is important to consider marine organisms’ research. For this reason, the objective of the review is to present an update of the most relevant information that exists around the physiology of marine invertebrate neuronal and glial cells.

1 April 2004 in Cell Biology International
Verified
Journal Article
Closed access
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
LNLuz Navarro
Luz Navarro
AGAlicia González
Alicia González
RDRene Drucker‐Colın
Rene Drucker‐Colın

5 September 2017 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
RTReynaldo Tiburcio-Félix
Reynaldo Tiburcio-Félix
MEMiguel Escalante-López
Miguel Escalante-López
BLBruno López-Bayghen
Bruno López-Bayghen
DMDaniel Martínez
Daniel Martínez
LHLuisa C. Hernández-Kelly
Luisa C. Hernández-Kelly
AOArturo Ortega
Arturo Ortega

31 January 2024 in Nutritional Neuroscience
Verified
Journal Article
Closed access
OMOrquídea G. Méndez-Flores
Orquídea G. Méndez-Flores
LHLuisa C. Hernández-Kelly
Luisa C. Hernández-Kelly
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
GLGabriel López-Ramírez
Gabriel López-Ramírez
AOArturo Ortega
Arturo Ortega
Neurons and glial cells are the main functional and structural elements of the brain, and the former depends on the latter for their nutritional, functional and structural organization, as well as for their energy maintenance. Glucose is the main metabolic source that fulfills energetic demands, either by direct anaplerosis or through its conversion to metabolic intermediates. Development of some neurodegenerative diseases have been related with modifications in the expression and/or function of glial glucose transporters, which might cause physiological and/or pathological disturbances of brain metabolism. In the present contribution, we summarized the experimental findings that describe the exquisite adjustment in expression and function of glial glucose transporters from physiologic to pathologic metabolism, and its relevance to neurodegenerative diseases. A exhaustive literature review was done in order to gain insight into the role of brain energetics in neurodegenerative disease. This study made evident a critical involvement of glucose transporters and thus brain energetics in the development of neurodegenerative diseases. An exquisite adjustment in the expression and function of glial glucose transporters from physiologic to pathologic metabolism is a biochemical signature of neurodegenerative diseases.